Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
Journal: Nature medicine
Published: February 18, 2022
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: February 20, 2019
Baseline characteristics and enrichment results from the SONAR trial.
Journal: Diabetes, obesity & metabolism
Published: January 30, 2018
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
Journal: Diabetes, obesity & metabolism
Published: September 19, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026